Oseltamivir in seasonal, avian H5N1 and pandemic 2009 A/H1N1 influenza: pharmacokinetic and pharmacodynamic characteristics.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Works matching IS 03125963 AND DT 2010 AND VI 49 AND IP 11
Results: 6
1
2
Plasma Anti-Xa Monitoring for Low-Molecular-Weight Heparins in Patients with Chronic Kidney Disease.
- Published in:
- Clinical Pharmacokinetics, 2010, v. 49, n. 11, p. 773, doi. 10.2165/11534810-000000000-00000
- Publication type:
- Article
3
Fluoxetine Disposition in Patients with Chronic Hepatitis C Treated with Interferon-α.
- Published in:
- Clinical Pharmacokinetics, 2010, v. 49, n. 11, p. 767, doi. 10.2165/11534720-000000000-00000
- Publication type:
- Article
4
Oseltamivir in Seasonal, Avian H5N1 and Pandemic 2009 A/H1N1 Influenza.
- Published in:
- Clinical Pharmacokinetics, 2010, v. 49, n. 11, p. 741, doi. 10.2165/11534730-000000000-00000
- Publication type:
- Article
5
Pharmacokinetic and Pharmacodynamic Perspectives on the Clinical Drug Development of Panitumumab.
- Published in:
- Clinical Pharmacokinetics, 2010, v. 49, n. 11, p. 729, doi. 10.2165/11535970-000000000-00000
- Publication type:
- Article
6
A Quantitative Framework and Strategies for Management and Evaluation of Metabolic Drug-Drug Interactions in Oncology Drug Development.
- Published in:
- Clinical Pharmacokinetics, 2010, v. 49, n. 11, p. 703, doi. 10.2165/11536740-000000000-00000
- Publication type:
- Article